In aging research, the compound provides a unique approach to investigating theories of metabolic decline, as NNMT expression increases with age in many tissues, potentially contributing to the NAD+ decline associated with aging processes
TSW patients can also request a Certificate of Analysis that walks through the detailed testing results of their own medication
Both Retatrutide and AOD-9604 are available as research peptides in Canada
CPT Code 62323: Description and Clinical Context According to the American Medical Association (AMA), CPT code 62323 is defined as: Injection(s), of diagnostic or therapeutic substance(s) (e.g., anesthetic, antispasmodic, opioid, steroid, other solution), not including neurolytic substances, including needle or catheter placement, interlaminar epidural or subarachnoid
Care should be taken to avoid accidental self-injection: may cause irritation at site of injection
Based on clinical trial data, semaglutide is dramatically more effective than AOD 9604 for weight loss